title: Recombinant activated factor VII administration after pulmonary embolectomy: case report.
abstract: Bleeding management in cardiac surgery could be a great challenge for the surgeon and a life-threatening moment for the patient. Despite the fact that recombinant activated factor VII is now widely accepted as a useful adjunct in the management of postcardiotomy coagulopathy, its use in the course of recent thromboembolic event is rarely described. We hereby present a case of rescue recombinant activated factor VII administration to manage a severe coagulation disorder during surgical pulmonary embolectomy performed under cardiopulmonary bypass.
authors: Department of Cardiac Surgery, Charles University in Prague, Hradec Kralove, Czech Republic. nidal81@gmail.com
authors: Nedal
authors: N
authors: Omran
authors: Jan
authors: J
authors: Harrer
authors: Miroslav
authors: M
authors: Brtko
authors: Petr
authors: P
authors: Habal
authors: Zdenek
authors: Z
authors: Turek
authors: Marek
authors: M
authors: Pojar
authors: Jan
authors: J
authors: Brozik
mesh_terms: D001778:Blood Coagulation Disorders / Q000150:complications* / Q000188:drug therapy*; D003029:Coagulants / Q000008:administration & dosage; D017128:Embolectomy / Q000009:adverse effects*; D005167:Factor VII / Q000008:administration & dosage* / Q000235:genetics; D006801:Humans; D008297:Male; D008875:Middle Aged; D019106:Postoperative Hemorrhage / Q000209:etiology* / Q000517:prevention & control*; D011655:Pulmonary Embolism / Q000150:complications / Q000601:surgery*; D011994:Recombinant Proteins / Q000009:adverse effects; D016896:Treatment Outcome
chemical_list: D003029:Coagulants; D011994:Recombinant Proteins; D005167:Factor VII